Company Data
Acumen Pharmaceuticals Inc.
Ticker
ABOS
Current Price
$1.745 -3.86%
Market Cap
$126.2M
Price Target
Refer to Report
Volume
619.7K
52wk Range
$1.5 - $3.6
Overview
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer’s disease. The company’s lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.